De Novo Sequence and Copy Number Variants Are Strongly Associated with Tourette Disorder and Implicate Cell Polarity in Pathogenesis

Jeffrey D. Mandell | Stephan J Sanders | N. Freimer | J. Buxbaum | P. Paschou | B. Neale | M. Okun | D. Posthuma | J. Leckman | V. Roessner | Jinchuan Xing | M. State | H. Singer | S. Kuperman | G. Coppola | Dongmei Yu | J. Scharf | L. Davis | J. Sul | V. Ramensky | G. Lyon | Juan Arbelaez | M. Grados | D. Pauls | R. King | I. Heyman | C. Huyser | D. Gilbert | A. Willsey | Y. Bromberg | P. Hoekstra | M. Robertson | P. Sandor | G. Rouleau | I. Malaty | J. Tischfield | R. Kurlan | K. Müller-Vahl | A. Morer | K. Plessen | C. Mathews | A. Münchau | D. Cath | K. Cheon | Young-Shin Kim | Yun-Joo Koh | L. Osiecki | C. Barr | R. Bruun | C. Budman | S. Chouinard | Y. Dion | T. Fernandez | G. Heiman | C. Illmann | A. Huang | P. Mir | Shan Dong | S. De Rubeis | A. Dietrich | M. Abdulkadir | B. Coffey | L. Deng | Lonneke Elzerman | B. Garcia-Delgar | D. Grice | Julie Hagstrøm | T. Hedderly | H. Hong | Y. Kim | S. Kook | A. Ludolph | A. Maras | T. Murphy | Cara Nasello | Jungeun Song | Nawei Sun | J. Tübing | F. Visscher | Sina Wanderer | Martin L. Woods | Yeting Zhang | S. Zinner | J. Batterson | C. Berlin | S. Darrow | M. Hirschtritt | Jan Smit | L. W. Brown | Hannah Poisner | Yogesh Kumar | P. Janik | N. Dahl | B. Bodmer | R. Rizzo | T. Wolańczyk | Z. Tarnok | C. Barta | Clif Duhn | C. Androutsos | G. Rouleau | S. S. Padmanabhuni | C. Żekanowski | Matthew E. Hirschtritt | M. Morris | P. Nagy | I. Karagiannidis | J. Fichna | Zhiyu Yang | N. Szejko | L. Farkas | N. Cox | U. Szymańska | Xin Zhao | N. Khalifa | B. Leventhal | Carolin Fremer | N. Sun | J. Arbelaez | C. Duhn | Eun-Joo Kim | A. Koumoula | M. Madruga‐Garrido | Marianthi Georgitsi | Eun-young Shin | N. Freimer | V. Tsironi | Sheng Wang | Xin Zhao | Dongya Song | Joshua K. Thackray | J. Puchała | W. MacMahon | Lawrence W. Brown | Bennett L. Leventhal | K. Müller‐Vahl | Veit Roessner | C. Fremer | J. Puchala | Robert A. King | Shanmukha S. Padmanabhuni | William M. MacMahon | Yogesh Kumar | Jennifer Tübing | Silvia De Rubeis | L. Davis | Alden Huang | Hannah Poisner

[1]  Nevan J. Krogan,et al.  The Psychiatric Cell Map Initiative: A Convergent Systems Biological Approach to Illuminating Key Molecular Pathways in Neuropsychiatric Disorders , 2018, Cell.

[2]  M. Daly,et al.  ASD and ADHD have a similar burden of rare protein-truncating variants , 2018, bioRxiv.

[3]  J. Quezada,et al.  Current Approaches and New Developments in the Pharmacological Management of Tourette Syndrome , 2018, CNS Drugs.

[4]  James D Stephenson,et al.  Quantifying the contribution of recessive coding variation to developmental disorders , 2017, Science.

[5]  James D Stephenson,et al.  Autosomal recessive coding variants explain only a small proportion of undiagnosed developmental disorders in the British Isles , 2017 .

[6]  Yufeng Shen,et al.  Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands , 2017, Nature Genetics.

[7]  J. Kennedy,et al.  De novo damaging coding mutations are strongly associated with obsessive-compulsive disorder and overlap with autism , 2017, bioRxiv.

[8]  Jeffrey D. Mandell,et al.  De Novo Coding Variants Are Strongly Associated with Tourette Disorder , 2017, Neuron.

[9]  Deciphering Developmental Disorders Study,et al.  Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.

[10]  The Gene Ontology Consortium,et al.  Expansion of the Gene Ontology knowledgebase and resources , 2016, Nucleic Acids Res..

[11]  The Gene Ontology Consortium.  Expansion of the Gene Ontology knowledgebase and resources , 2016, Nucleic Acids Res..

[12]  Douglas W. Woods,et al.  Rare Copy Number Variants in NRXN1 and CNTN6 Increase Risk for Tourette Syndrome , 2016, Neuron.

[13]  Stephan J Sanders,et al.  Refining the role of de novo protein truncating variants in neurodevelopmental disorders using population reference samples , 2016, Nature Genetics.

[14]  Rita M Cantor,et al.  Rare Inherited and De Novo CNVs Reveal Complex Contributions to ASD Risk in Multiplex Families. , 2016, American journal of human genetics.

[15]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[16]  Stephan J Sanders,et al.  De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies , 2015, Science.

[17]  Christopher S. Poultney,et al.  Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci , 2015, Neuron.

[18]  Michael R. Johnson,et al.  Copy number variant analysis from exome data in 349 patients with epileptic encephalopathy , 2015, Annals of neurology.

[19]  Stephan J Sanders,et al.  The female protective effect in autism spectrum disorder is not mediated by a single genetic locus , 2015, Molecular Autism.

[20]  Kali T. Witherspoon,et al.  Excess of rare, inherited truncating mutations in autism , 2015, Nature Genetics.

[21]  Yoav Ben-Shlomo,et al.  Population prevalence of Tourette syndrome: A systematic review and meta‐analysis , 2015, Movement disorders : official journal of the Movement Disorder Society.

[22]  Boris Yamrom,et al.  The contribution of de novo coding mutations to autism spectrum disorder , 2014, Nature.

[23]  Christopher S. Poultney,et al.  Synaptic, transcriptional, and chromatin genes disrupted in autism , 2014, Nature.

[24]  J. Long,et al.  Illumina human exome genotyping array clustering and quality control , 2014, Nature Protocols.

[25]  Kathryn Roeder,et al.  De novo insertions and deletions of predominantly paternal origin are associated with autism spectrum disorder. , 2014, Cell reports.

[26]  Epilepsy Phenome,et al.  De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. , 2014, American journal of human genetics.

[27]  Edouard Henrion,et al.  De Novo Mutations in Moderate or Severe Intellectual Disability , 2014, PLoS genetics.

[28]  Dan J Stein,et al.  Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study. , 2014, Journal of the American Academy of Child and Adolescent Psychiatry.

[29]  Peter Holmans,et al.  De novo CNVs in bipolar affective disorder and schizophrenia , 2014, Human molecular genetics.

[30]  L. Vissers,et al.  Genome sequencing identifies major causes of severe intellectual disability , 2014, Nature.

[31]  M. State,et al.  The Tourette International Collaborative Genetics (TIC Genetics) study, finding the genes causing Tourette syndrome: objectives and methods , 2014, European Child & Adolescent Psychiatry.

[32]  Sven Bergmann,et al.  A higher mutational burden in females supports a "female protective model" in neurodevelopmental disorders. , 2014, American journal of human genetics.

[33]  E. Banks,et al.  De novo mutations in schizophrenia implicate synaptic networks , 2014, Nature.

[34]  Lars Feuk,et al.  The Database of Genomic Variants: a curated collection of structural variation in the human genome , 2013, Nucleic Acids Res..

[35]  P. Sullivan,et al.  Detecting large copy number variants using exome genotyping arrays in a large Swedish schizophrenia sample , 2013, Molecular Psychiatry.

[36]  Mauricio O. Carneiro,et al.  From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.

[37]  Kathryn Roeder,et al.  Integrated Model of De Novo and Inherited Genetic Variants Yields Greater Power to Identify Risk Genes , 2013, PLoS genetics.

[38]  N. Freimer,et al.  CNV Analysis in Tourette Syndrome Implicates Large Genomic Rearrangements in COL8A1 and NRXN1 , 2013, PloS one.

[39]  I. Adzhubei,et al.  Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2 , 2013, Current protocols in human genetics.

[40]  S. E. Stewart,et al.  Genome-wide association study of Tourette Syndrome , 2012, Molecular Psychiatry.

[41]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..

[42]  B. V. van Bon,et al.  Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, The New England journal of medicine.

[43]  D. Horn,et al.  Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study , 2012, The Lancet.

[44]  P. Paschou,et al.  Replication of association between a SLITRK1 haplotype and Tourette Syndrome in a large sample of families , 2012, Molecular Psychiatry.

[45]  Bradley P. Coe,et al.  Copy number variation detection and genotyping from exome sequence data , 2012, Genome research.

[46]  Kenny Q. Ye,et al.  De Novo Gene Disruptions in Children on the Autistic Spectrum , 2012, Neuron.

[47]  Michael F. Walker,et al.  De novo mutations revealed by whole-exome sequencing are strongly associated with autism , 2012, Nature.

[48]  Joseph T. Glessner,et al.  Rare Copy Number Variants in Tourette Syndrome Disrupt Genes in Histaminergic Pathways and Overlap with Autism , 2012, Biological Psychiatry.

[49]  Bradley P. Coe,et al.  Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations , 2012, Nature.

[50]  J. Sebat,et al.  High Frequencies of De Novo CNVs in Bipolar Disorder and Schizophrenia , 2011, Neuron.

[51]  Kathryn Roeder,et al.  Multiple Recurrent De Novo CNVs, Including Duplications of the 7q11.23 Williams Syndrome Region, Are Strongly Associated with Autism , 2011, Neuron.

[52]  Boris Yamrom,et al.  Rare De Novo and Transmitted Copy-Number Variation in Autistic Spectrum Disorders , 2011, Neuron.

[53]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[54]  C. Lord,et al.  The Simons Simplex Collection: A Resource for Identification of Autism Genetic Risk Factors , 2010, Neuron.

[55]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[56]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[57]  H. Chugani,et al.  Tourette syndrome is associated with recurrent exonic copy number variants , 2010, Neurology.

[58]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[59]  L. Goutebroze,et al.  Axonal targeting of Caspr2 in hippocampal neurons via selective somatodendritic endocytosis , 2009, Journal of Cell Science.

[60]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[61]  A. Ghanizadeh,et al.  Psychiatric disorders and behavioral problems in children and adolescents with Tourette syndrome , 2009, Brain and Development.

[62]  L. Scahill,et al.  Prevalence of diagnosed tourette syndrome in persons aged 6-17 years - United States, 2007. , 2009 .

[63]  T. Popović,et al.  Prevalence of diagnosed Tourette syndrome in persons aged 6-17 years - United States, 2007. , 2009, MMWR. Morbidity and mortality weekly report.

[64]  M. Robertson.  The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies. , 2008, Journal of psychosomatic research.

[65]  Richard P Lifton,et al.  Disruption of Contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome. , 2004, American journal of human genetics.

[66]  Joseph T. Glessner,et al.  PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. , 2007, Genome research.

[67]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[68]  P. Heutink,et al.  CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. , 2003, Genomics.

[69]  Paul Sandor,et al.  An international perspective on Tourette syndrome: selected findings from 3500 individuals in 22 countries , 2000, Developmental medicine and child neurology.

[70]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[71]  D. Pauls.  A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome. The Tourette Syndrome Association International Consortium for Genetics. , 1999, American journal of human genetics.

[72]  Y. Taketani,et al.  cDNA cloning and chromosomal localization of neural adhesion molecule NB‐3 in human , 1998, Journal of neuroscience research.

[73]  T. Südhof,et al.  Neurexins: synaptic cell surface proteins related to the alpha-latrotoxin receptor and laminin. , 1992, Science.

[74]  K. Kidd,et al.  A twin study of Tourette syndrome. , 1985, Archives of general psychiatry.

[75]  K. Kidd,et al.  Familial pattern and transmission of Gilles de la Tourette syndrome and multiple tics. , 1981, Archives of general psychiatry.